InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-02 · accession 0000950170-25-032183 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-04 2025-03-02+ APVO Taylor Daphne SVP, CFO M - OptEx — +3 18 +20% —
DM 2025-03-04 2025-03-02+ APVO Taylor Daphne SVP, CFO M - OptEx $0.00 -3 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-02 M A 2 — 17 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2025-03-04 M A 1 — 18 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2025-03-02 M D 2 $0.00 2 D — · — to — 2 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
4 Derivative Restricted Stock Unit 2025-03-04 M D 1 $0.00 0 D — · — to — 1 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.